On 19 MAY, GlaxoSmithKline plc (ADR) (NYSE:GSK) announced a dividend, which is scheduled for Thursday, July 10th. Shareholders of record on Wednesday, May 14th will be paid a dividend of GBX 19 ($0.32) per share. This represents a dividend yield of 1.17. GlaxoSmithKline plc (ADR) (NYSE:GSK) net profit margin is 27.60% and weekly performance is -1.06%. On last trading day company shares ended up $54.84. Analysts mean target price for the company is $60.33. GlaxoSmithKline plc (ADR) (NYSE:GSK) distance from 50-day simple moving average (SMA50) is 2.21%.
On 23 MAY Elite Pharmaceuticals Inc (OTCBB:ELTP) announced the voting results of matters considered during the Company’s annual meeting of shareholders held on May 21, 2014. Of the shares entitled to vote at this meeting, 89.18% shares were voted for this meeting. Elite Pharmaceuticals Inc (OTCBB: ELTP) shares advanced 1.31% in last trading session and ended the day on $0.395.
On 22 MAY TherapeuticsMD Inc. (NYSEMKT: TXMD) announced that the Company will present at the Jefferies 2014 Global Healthcare Conference taking place at the Grand Hyatt in New York City on June 2-5 2014. TherapeuticsMD Inc (NYSEMKT: TXMD) shares moved up 0.78% in last trading session and was closed at $3.87, while trading in range of $3.81 – $3.95. TherapeuticsMD Inc (NYSEMKT: TXMD) year to date (YTD) performance is -25.72%.
On 23 MAY Galena Biopharma Inc (NASDAQ:GALE) announced that Ryan Dunlap, Vice President and Chief Financial Officer, will present a corporate update at the Marcum MicroCap Conference. The presentation will take place on Thursday, May 29, 2014 at 10:00 a.m. ET at The Grand Hyatt Hotel in New York City. Galena Biopharma Inc (NASDAQ:GALE) ended the last trading day at $2.30. Company weekly volatility is calculated as 7.26% and price to cash ratio as 5.18. Galena Biopharma Inc (NASDAQ:GALE) showed a positive weekly performance of 5.99%.
On 20 MAY Roche Holding Ltd. (ADR) (OTCMKTS: RHHBY) announced the establishment of a strategic alliance with Pathology, Inc. in Torrance, Calif., that designates the company as a Roche Molecular Center of Excellence (MCOE) for the next five years. Roche Holding Ltd. (ADR) (OTCMKTS: RHHBY) on last trading day company shares ended up $37.42.